These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 18606544)
1. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544 [TBL] [Abstract][Full Text] [Related]
2. Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules. Kánai K; Arányi P; Böcskei Z; Ferenczy G; Harmat V; Simon K; Bátori S; Náray-Szabo G; Hermecz I J Med Chem; 2008 Dec; 51(23):7514-22. PubMed ID: 19006380 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of prolyl oligopeptidase with a synthetic unnatural dipeptide. Racys DT; Rea D; Fülöp V; Wills M Bioorg Med Chem; 2010 Jul; 18(13):4775-82. PubMed ID: 20627594 [TBL] [Abstract][Full Text] [Related]
4. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design. Tully DC; Vidal A; Chatterjee AK; Williams JA; Roberts MJ; Petrassi HM; Spraggon G; Bursulaya B; Pacoma R; Shipway A; Schumacher AM; Danahay H; Harris JL Bioorg Med Chem Lett; 2008 Nov; 18(22):5895-9. PubMed ID: 18752942 [TBL] [Abstract][Full Text] [Related]
5. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions. Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257 [TBL] [Abstract][Full Text] [Related]
6. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides. Wallén EA; Christiaans JA; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J J Med Chem; 2003 Oct; 46(21):4543-51. PubMed ID: 14521416 [TBL] [Abstract][Full Text] [Related]
7. From natural products to achiral drug prototypes: potent thrombin inhibitors based on P2/P3 dihydropyrid-2-one core motifs. Hanessian S; Therrien E; Zhang J; Otterlo Wv; Xue Y; Gustafsson D; Nilsson I; Fjellström O Bioorg Med Chem Lett; 2009 Sep; 19(18):5429-32. PubMed ID: 19674897 [TBL] [Abstract][Full Text] [Related]
10. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors. Jarho EM; Venäläinen JI; Huuskonen J; Christiaans JA; Garcia-Horsman JA; Forsberg MM; Järvinen T; Gynther J; Männistö PT; Wallén EA J Med Chem; 2004 Nov; 47(23):5605-7. PubMed ID: 15509157 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of N-acyl-Gly-, N-acyl-Sar- and N-blocked-boroPro inhibitors of FAP, DPP4, and POP. Tran T; Quan C; Edosada CY; Mayeda M; Wiesmann C; Sutherlin D; Wolf BB Bioorg Med Chem Lett; 2007 Mar; 17(5):1438-42. PubMed ID: 17174090 [TBL] [Abstract][Full Text] [Related]